4
Changes in Ownership
CORCEPT THERAPEUTICS INC Filed Acc 0001193125-25-196317
See Remarks sold 5,000 shares at an average $70.25 ($351,247)
- See Remarks acquired 5,000 shares (option exercise)
- See Remarks acquired 400 shares (grant or award)
- See Remarks gave up 189 shares (to pay taxes)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Lyon Joseph Douglas See Remarks | 2025-09-02 | Option exercise 10b5-1 | +5,000 | $13.56 | $67,800 | 15,066 | D: show line 1 in the form |
| Lyon Joseph Douglas See Remarks | 2025-09-02 | Sale 10b5-1 | −4,895 | $70.24 | $343,818 | 10,171 | D: show line 2 in the form |
| Lyon Joseph Douglas See Remarks | 2025-09-02 | Sale 10b5-1 | −105 | $70.76 | $7,429 | 10,066 | D: show line 3 in the form |
| Lyon Joseph Douglas See Remarks | 2025-09-02 | Grant or award 10b5-1 | +200 | $71.38 | $14,276 | 10,266 | D: show line 4 in the form |
| Lyon Joseph Douglas See Remarks | 2025-09-02 | Grant or award 10b5-1 | +200 | 10,466 | D: show line 5 in the form | ||
| Lyon Joseph Douglas See Remarks | 2025-09-03 | Shares withheld for taxes 10b5-1 | −189 | $71.38 | $13,491 | 10,277 | D: show line 6 in the form |
| Open-market sales · 5,000 sh · avg $70.25 · $351,247 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Lyon Joseph Douglas See Remarks | 2025-09-02 | Option exercise · Stock option (right to buy) 10b5-1 | −5,000 | 26,571 | D: show line 7 in the form |
Loading xslF345X05/ownership.xml…